Drug discovery startup Pepper Bio hopes to challenge Eroom’s law with new funding
The biotech startup’s $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
